Candriam Equities L Biotech.R-H CHF Acc/ LU1269736754 /
| NAV1/23/2025 | Chg.+3.1500 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 202.8400CHF | +1.58% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | - | - | - | - | - | 3.81 | -8.64 | -3.97 | -2.99 | - |
| 2017 | 5.37 | 6.71 | -0.01 | 0.96 | -3.17 | 9.25 | 2.21 | 6.79 | 0.75 | -6.79 | -0.06 | 1.28 | +24.55% |
| 2018 | 6.46 | -4.80 | -2.39 | -3.41 | 4.34 | 0.58 | 4.21 | 3.87 | -2.28 | -14.26 | 3.88 | -8.61 | -13.65% |
| 2019 | 12.82 | 3.37 | -0.81 | -5.23 | -4.67 | 9.15 | -2.44 | -2.53 | -4.73 | 10.96 | 11.86 | 2.51 | +31.48% |
| 2020 | -5.43 | -1.60 | -5.43 | 12.23 | 9.44 | 1.20 | -3.00 | 0.78 | 0.58 | -2.71 | 9.32 | 2.87 | +17.67% |
| 2021 | 1.79 | -2.63 | -4.46 | 2.68 | -2.30 | 6.28 | -1.49 | 3.84 | -4.29 | 0.13 | -4.43 | 2.29 | -3.23% |
| 2022 | -10.64 | -1.64 | 5.83 | -7.32 | -4.11 | 3.15 | 4.61 | 1.26 | -2.38 | 6.20 | 5.78 | -3.39 | -4.31% |
| 2023 | 2.65 | -5.92 | -0.03 | 1.99 | -1.27 | 1.11 | -0.85 | -0.55 | -4.78 | -6.38 | 5.73 | 13.17 | +3.40% |
| 2024 | 1.22 | 1.02 | -0.28 | -6.53 | 3.45 | 5.35 | 6.03 | 1.43 | -2.69 | -1.81 | 0.20 | -7.38 | - |
| 2025 | 0.65 | - | - | - | - | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 19.36% | 18.78% | 17.56% | 20.25% | 22.80% |
| Sharpe ratio | 0.45 | -1.07 | -0.26 | 0.07 | -0.01 |
| Best month | +0.65% | +6.03% | +6.03% | +13.17% | +13.17% |
| Worst month | -7.38% | -7.38% | -7.38% | -10.64% | -10.64% |
| Maximum loss | -4.23% | -14.92% | -14.92% | -20.92% | -31.53% |
| Outperformance | -5.08% | - | -3.25% | - | - |
All quotes in CHF
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,106.6101 | +1.48% | +17.39% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,389.5300 | +7.69% | +37.58% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,626.2000 | +6.22% | +38.00% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,920.0500 | +2.78% | +28.71% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 236.7900 | +7.14% | +37.44% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 382.6700 | +6.66% | +41.80% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 351.5400 | +8.13% | +41.19% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.8400 | -0.69% | +14.29% | |
| Candriam Equities L Biotechnolog... | reinvestment | 152.1200 | -1.32% | - | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,829.2002 | +3.39% | +26.49% | |
| Candriam Equities L Biotechnolog... | reinvestment | 2,132.0000 | +3.49% | +27.03% | |
| Candriam Equities L Biotech.N US... | reinvestment | 618.0500 | +2.50% | +25.06% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 201.4100 | +1.01% | +17.41% | |
| Candriam Equities L Biotech.R US... | reinvestment | 277.8900 | +3.80% | +29.82% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 211.2200 | +1.86% | +20.39% | |
| Candriam Equities L Biotechnolog... | reinvestment | 869.7200 | +2.88% | +26.55% | |
| Candriam Equities L Biotechnolog... | paying dividend | 794.1400 | +2.85% | +26.44% |
Performance
| YTD | +2.24% | ||
|---|---|---|---|
| 6 Months | -7.75% | ||
| 1 Year | -0.69% | ||
| 3 Years | +14.29% | ||
| 5 Years | +15.55% | ||
| Since start | +35.23% | ||
| Year | |||
| 2023 | +3.40% | ||
| 2022 | -4.31% | ||
| 2021 | -3.23% | ||
| 2020 | +17.67% | ||
| 2019 | +31.48% | ||
| 2018 | -13.65% | ||
| 2017 | +24.55% | ||